Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3830-3841
Published online before print December 13, 2004, doi: 10.1161/01.CIR.0000148681.01282.89
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/25/3830    most recent
01.CIR.0000148681.01282.89v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merched, A. J.
Right arrow Articles by Chan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merched, A. J.
Right arrow Articles by Chan, L.
Related Collections
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrowRelated Article

(Circulation. 2004;110:3830-3841.)
© 2004 American Heart Association, Inc.


Vascular Medicine

Absence of p21Waf1/Cip1/Sdi1 Modulates Macrophage Differentiation and Inflammatory Response and Protects Against Atherosclerosis

Aksam J. Merched, PhD; Lawrence Chan, MBBS, DSc

From the Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Tex.

Correspondence to Dr Aksam Merched or Dr Lawrence Chan, Departments of Molecular and Cellular Biology and Medicine, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. E-mail amerched{at}bcm.tmc.edu or lchan@bcm.tmc.edu

Received May 26, 2004; revision received September 17, 2004; accepted October 1, 2004.

Background— The tumor suppressor p53 protects against atherosclerosis progression in several different mouse models. A major target of p53 is p21, the cyclin-dependent kinase inhibitor that regulates entry into the cell cycle of different types of cells, including stem cells. p21 is also involved in the maturation and differentiation of monocytes into macrophages.

Methods and Results— We studied the effect of p21Waf1 inactivation on atherosclerosis development in apolipoprotein E-deficient mice (apoE/). Contrary to previous data suggesting a protective role for p21, we found that absence of p21, either globally or in bone marrow-derived cells, protects against atherosclerosis. Atherosclerotic lesions of p21//apoE/ mice exhibit a more stable phenotype, with increased apoptosis and reduced inflammatory vascular cell adhesion molecule-1 immunostaining but no difference in cellular proliferation compared with lesions of p21+/+/apoE/ mice. Because bone marrow-derived cells mediate many of the effects of p21, we examined the expression profile of 23 genes in macrophages using real-time polymerase chain reaction. Compared with their p21+/+ counterparts, peritoneal macrophages of p21/ mice express lower levels of proinflammatory markers, including macrophage inflammatory proteins 1 and 2 and interleukin-1{alpha}, and higher levels of putative protective genes, such as scavenger receptor type B-I and LDL receptor-related protein. Furthermore, we found that, in comparison with p21+/+ macrophages, p21/ macrophages displayed increased phagocytic activity toward fluorescent latex microspheres as well as apoptotic cells, thus uncovering a novel mechanism of the antiinflammatory activity of p21/ macrophages.

Conclusions— Loss of p21 protects against atherosclerosis in apoE/ mice. The data underscore the important role of p21 in macrophage function and inflammation and provide insight into the mechanism of the proatherogenic effect of p21.


Key Words: apoptosis • inflammation • atherosclerosis • phagocytosis • cell cycle


Related Article:

Unexpected Proatherogenic Properties of p21: Beyond Cell Cycle Control?
Vicente Andrés
Circulation 2004 110: 3749-3752. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Merched, K. Tollefson, and L. Chan
{beta}2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice
Cardiovasc Res, November 21, 2009; (2009) cvp347v2.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. J. Merched, K. Ko, K. H. Gotlinger, C. N. Serhan, and L. Chan
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
FASEB J, October 1, 2008; 22(10): 3595 - 3606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Inoue, N. Yahagi, T. Yamamoto, M. Ishikawa, K. Watanabe, T. Matsuzaka, Y. Nakagawa, Y. Takeuchi, K. Kobayashi, A. Takahashi, et al.
Cyclin-dependent Kinase Inhibitor, p21WAF1/CIP1, Is Involved in Adipocyte Differentiation and Hypertrophy, Linking to Obesity, and Insulin Resistance
J. Biol. Chem., July 25, 2008; 283(30): 21220 - 21229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman
Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 7 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. M. Tuder, J. H. Yun, and B. B. Graham
Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cheng, J. Zhang, A. Merched, L. Zhang, P. Zhang, L. Truong, A. M. Boriek, and J. Du
Mechanical Stretch Inhibits Oxidized Low Density Lipoprotein-induced Apoptosis in Vascular Smooth Muscle Cells by Up-regulating Integrin {alpha}Vbeta3 and Stablization of PINCH-1
J. Biol. Chem., November 23, 2007; 282(47): 34268 - 34275.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Klingenberg, J.-R. Nofer, M. Rudling, F. Bea, E. Blessing, M. Preusch, H. J. Grone, H. A. Katus, G. K. Hansson, and T. J. Dengler
Sphingosine-1-Phosphate Analogue FTY720 Causes Lymphocyte Redistribution and Hypercholesterolemia in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. S. Santiago, H. Ishii, S. Shafi, R. Khurana, P. Kanellakis, R. Bhindi, M. J. Ramirez, A. Bobik, J. F. Martin, C. N. Chesterman, et al.
Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly
Circ. Res., July 20, 2007; 101(2): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Minamino and I. Komuro
Vascular Cell Senescence: Contribution to Atherosclerosis
Circ. Res., January 5, 2007; 100(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Kunieda, T. Minamino, J.-i. Nishi, K. Tateno, T. Oyama, T. Katsuno, H. Miyauchi, M. Orimo, S. Okada, M. Takamura, et al.
Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway
Circulation, August 29, 2006; 114(9): 953 - 960.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. D. Patino, J.-G. Kang, S. Matoba, O. Y. Mian, B. R. Gochuico, and P. M. Hwang
Atherosclerotic Plaque Macrophage Transcriptional Regulators Are Expressed in Blood and Modulated by Tristetraprolin
Circ. Res., May 26, 2006; 98(10): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. S. M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, L. Hu, J. Jonkers, B. van de Water, M. J. J. Gijbels, I. van der Made, M. P. J. de Winther, L. M. Havekes, et al.
Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice
FASEB J, May 1, 2006; 20(7): 953 - 955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. C. Scatizzi, J. Hutcheson, E. Bickel, J. M. Woods, K. Klosowska, T. L. Moore, G. K. Haines III, and H. Perlman
p21Cip1 Is Required for the Development of Monocytes and Their Response to Serum Transfer-induced Arthritis
Am. J. Pathol., May 1, 2006; 168(5): 1531 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rosso, A. Balsamo, R. Gambino, P. Dentelli, R. Falcioni, M. Cassader, L. Pegoraro, G. Pagano, and M. F. Brizzi
p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes
J. Biol. Chem., February 17, 2006; 281(7): 4339 - 4347.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. P. Lau, L. Li, A. J. Merched, A. L. Zhang, K. W.S. Ko, and L. Chan
Nicotine Induces Proinflammatory Responses in Macrophages and the Aorta Leading to Acceleration of Atherosclerosis in Low-Density Lipoprotein Receptor-/- Mice
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 143 - 149.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Andres
Unexpected Proatherogenic Properties of p21: Beyond Cell Cycle Control?
Circulation, December 21, 2004; 110(25): 3749 - 3752.
[Full Text] [PDF]